TrialDiabetes, obesity & metabolism2020

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial.

Martin Haluzík et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.